Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 457 | 444 | 539 | 320 | 326 |
| Income taxes - deferred | 1,220 | 1,072 | -116 | 121 | 981 |
| Accounts receivable | 1,657 | -385 | 3,006 | -2,817 | 884 |
| Accounts payable and accrued liabilities | -433 | 879 | 1,023 | 191 | -274 |
| Other Working Capital | 1,468 | 136 | 4,350 | -2,341 | 905 |
| Other Operating Activity | 2,495 | 2,968 | 1,934 | 7,897 | 1,414 |
| Operating Cash Flow | $6,864 | $5,114 | $10,736 | $3,371 | $4,236 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -42 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -55,432 | -74,608 | -108,260 | -104,492 | -51,251 |
| Sale Of Investment | 101,661 | 59,535 | 87,037 | 110,101 | 23,349 |
| Purchase Sale Intangibles | -3,000 | 0 | 0 | 0 | 0 |
| Other Investing Activity | 33,440 | -741 | -9,179 | 459 | 28,058 |
| Investing Cash Flow | $76,627 | $-15,814 | $-30,402 | $6,068 | $156 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 0 | 0 | 50 | 43 |
| Other Financing Activity | 49 | 247 | 61 | 0 | 345 |
| Financing Cash Flow | $49 | $247 | $61 | $50 | $388 |
| Exchange Rate Effect | 3,408 | 74 | -1,435 | -1,132 | -200 |
| Beginning Cash Position | 496,460 | 506,839 | 527,879 | 519,522 | 514,942 |
| End Cash Position | 583,408 | 496,460 | 506,839 | 527,879 | 519,522 |
| Net Cash Flow | $83,540 | $-10,453 | $-19,605 | $9,489 | $4,780 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,864 | 5,114 | 10,736 | 3,371 | 4,236 |
| Capital Expenditure | -3,042 | N/A | N/A | N/A | N/A |
| Free Cash Flow | 3,822 | 5,114 | 10,736 | 3,371 | 4,236 |